Buccoadhesive drug delivery systems: A review

International Journal of Pharma and Bio Sciences

Volumn 1, Issue 2, 2010, Pages

  Bhalodia, Ravi ^a   Basu, Biswajit ^a   Garala, Kevin ^a   Joshi, Bhavik ^a   Mehta, Kuldeep ^a  

^a Atmiya Institute of Pharmacy   (India)

Author keywords

Buccoadhesive drug delivery; Mucoadhesion; Polymers

Indexed keywords

LECTIN; POLYMER;

CONCENTRATION (PARAMETERS); CROSS LINKING; DIFFUSION COEFFICIENT; DRUG ADSORPTION; DRUG DESIGN; DRUG DOSAGE FORM; ENVIRONMENTAL FACTOR; FUNCTIONAL ANATOMY; HUMAN; HYDROGEN BOND; MOLECULAR WEIGHT; MOUTH CAVITY; MUCOADHESION; ORAL DRUG ADMINISTRATION; PERMEABILITY BARRIER; REVIEW; STRUCTURE ANALYSIS; WATER ABSORPTION;

EID: 81255170564     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Review

References (172)

1. N. K. Jain. Controlled and novel drug delivery. 1st ed. CBS Publishers, New Delhi, 2002.
2. V. M. Patel, B. G. Prajapati, M. M. Patel. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech 8(1):E1-8 (2007).
3. N. S. Miller, M. Chittchang, T. P. Johnston. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 57:1666-91 (2005).
4. S. P. Vyas, R. K. Khar. Controlled drug delivery-concepts and advances. 1st ed. Vallabh Prakashan, New Delhi, 2002.
5. A. H. Shojaei. Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci 1(1):15-30 (1998).
6. Y. S. Chen, C. A. Squier. The ultrastructure of the oral epithelium. In: J. Meyer, C. A. Squier, S. J. Gerson (eds.), The structure and function of oral mucosa, Pergamon Press, Oxford, 1984, pp. 7-30.
7. D. Harris, J. R. Robinson. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 81:1-10 (1992).
8. J. Meyer, S. J. Gerson. A comparison of human palatal and buccal mucosa. Periodontics 2:284-91 (1964).
9. R. B. Gandhi, J. R. Robinson. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev 13:43-74 (1994).
10. M. J. Stablein, J. Meyer. The vascular system and blood supply. In: J. Meyer, C. A. Squier, S. J. Gerson (eds.), The structure and function of oral mucosa, Pergamon Press, Oxford, 1984, pp. 237-56.
11. A. Allen, A. Bell, S. McQueen. Mucus and mucosal protection. In: A. Allen, G. Flemström, A. Garner, W. Silen, L. A. Turnberg (eds.), Mechanisms of mucosal protection in the upper gastrointestinal tract, Raven Press, New York, 1984, pp. 195-202.
12. G. P. Andrews, T. P. Laverty, D. S. Jones. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 71:505-18 (2009).
13. C. M. Lehr. From sticky stuff to sweet receptors-achievements, limits and novel approaches to bioadhesion. Eur J Drug Metab Pharmacokinet 21:139-48 (1996).
14. J. Haas, C. M. Lehr. Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther 2:287-98 (2002).
15. I. Fiebrig, S. Harding, A. Rowe, S. Hyman, S. Davis. Transmission electron microscopy studies on pig gastric mucin and its interactions with chitosan. Carbohydr Polym 28:239-44 (1995).
16. L. Serra, J. Doménech, N. A. Peppas. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm 71:519-28 (2009).
17. R. Willits, W. M. Saltzman. Synthetic polymers alter the structure of cervical mucus. Biomaterials 22:445-52 (2001).
18. A. F. Hayward. Membrane-coating granules. Int Rev Cyt 59:97-127 (1979).
19. C. A. Squier, R. A. Eady, R. M. Hopps. The permeability of epidermis lacking normal membrane-coating granules: an ultrastructural tracer study of Kyrle-Flegel disease. J Invest Dermatol 70:361-64 (1978).
20. I. A. Siegel, S. H. Hall, R. Stambaugh. Permeability of the oral mucosa. In: C. A. Squier, J. Meyer (eds.), Current concepts of the histology of oral mucosa, Springfield, IL: Carles Thomas; 1971, pp. 274-86.
21. Y. Oyama, H. Yamano, A. Ohkuma, K. Ogawara, K. Higaki, T. Kimura. Carriermediated transport systems for glucose in mucosal cells of the human oral cavity. J Pharm Sci 88:830-34 (1999).
22. N. Utoguchi, Y. Watanabe, T. Suzuki, J. Maehara, Y. Matsumoto, M. Matsumoto. Carrier-mediated transport of monocarboxylic acids in primary cultured epithelial cells from rabbit oral mucosa. Pharm Res 14:320-24 (1997).
23. N. Utoguchi, Y. Watanabe, Y. Takase, T. Suzuki, Matsumoto M. Carrier-mediated absorption of salicylic acid from hamster cheek pouch mucosa. J Pharm Sci 88:142-46 (1999).
24. D. F. Evered, J. V. Vadgama. Absorption of amino acids from the human buccal cavity. Biochem Soc Trans 9:132-33 (1981).
25. D. F. Evered, C. Mallett. Thiamine absorption across human buccal mucosa in vivo. Life Sci 32:1355-58 (1983).
26. J. R. Robinson, X. Yang. Absorption enhancers. In: J. Swarbrick, J. C. Boylan (eds.), Encyclopedia of pharmaceutical technology, Marcel Dekker Inc., New York, 2001, vol 18, pp. 1-27.
27. F. Veuillez, Y. N. Kalia, Y. Jacques, J. Deshusses, P. Buri. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm 51:93-109 (2001).
28. G. F. Walker, N. Langoth, A. Bernkop-Schnürch. Peptidase acitivity on the surface of the porcine buccal mucosa. Int J Pharm 233:141-47 (2002).
29. S. D. Kashi, V. H. L. Lee. Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases. Life Sci 38:2019-28 (1986).
30. M. A. Longer, J. R. Robinson. Fundamental aspects of bioadhesion. Pharm. Int. 7:114-17 (1986).
31. J. M. Gu, J. R. Robinson, S. H. S. Leung. Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carr Syst 5:21-67 (1998).
32. N. A.. Peppas, P. A. Buri. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release 2:257-75 (1985).
33. A. Ahuja, R. K. Khar, J. Ali. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 23:489-515 (1997).
34. Y. Huang, W. Leobandung, A. Foss, N. A. Peppas. Molecular aspects of muco- and bioadhesion: tethered structures and sitespecific surfaces. J Control Release 65:63-71 (2000).
35. A. Ahagon, A. N. Gent. Effect of interfacial bonding on the strength of adhesion. J Polym Sci Polym Phys 13:1285-1300 (1975).
36. A. J. Kinloch. The science of adhesion. J Mater Sci 15:2141-66 (1980).
37. J. W. Lee, J. H. Park, J. R. Robinson. Bioadhesive-based dosage forms: the next generation. J Pharm Sci 89:850-66 (2000).
38. D. Dodou, P. Breedveld, P. Wieringa. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm Biopharm 60:1-16 (2005).
39. M. I. Ugwoke, R. U. Agu, N. Verbeke, R. Kinget. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 57:1640-1665 (2005).
40. P. B. van Wachem, T. Beugeling, J. Feijen, A. Bantjes, J. P. Detmers, W. G. van Aken. Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials 6:403-8 (1985).
41. J. L. Chen, G. N. Cyr. Compositions producing adhesion through hydration. In: R. S. Manly (ed.), Adhesion in biological systems, Academic Press, New York, 1970, pp. 163-80.
42. H. Park, J. R. Robinson. Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res 4:457-64 (1987).
43. P. J. Flory. Principle of polymer chemistry. Cornell University Press, New York, 1953, pp. 541.
44. H. Park, M. Amiji, K. Park. Mucoadhesive hydrogels effective at neutral pH. Proc Int Symp Control Release Bioact Mater 16:217-18 (1989).
45. C. M. Lehr, J. A. Bouwstra, E. H. Schacht, H. E. Junginger. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 78:43-48 (1992).
46. D. Solomonidou, K. Cremer, M. Krumme, J. Kreuter. Effect of carbomer concentration and degree of neutralization on the mucoadhesive properties of polymer films. J Biomater Sci Polym Ed 12:1191-1205 (2001).
47. M. J. Rathbone, B. K. Drummond, I. G. Tucker. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 13:1-22 (1994).
48. C. M. Lehr, F. G. J. Poelma, H. E. Junginger, J. J. Tukker. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int J Pharm 70:235-40 (1991).
49. J. F. Forstner. Intestinal mucins in health and disease. Digestion 17:234-63 (1978).
50. N. F. H. Ho, C. L. Barsuhn, P. S. Burton, H. P. Merkle. (D) Routes of delivery: case studies. (3) Mechanistic insights to buccal delivery of proteinaceous substances. Adv Drug Deliv Rev 8:197-235 (1992).
51. A. Bernkop-Schnürch, V. Schwarz, S. Steininger. Polymers with thiol groups: a new generation of mucoadhesive polymers. Pharm Res 16:876-81 (1999).
52. N. Langoth, J. Kalbe, A. Bernkop-Schnürch. Development of buccal drug delivery systems based on a thiolated polymer. Int J Pharm 252:141-48 (2003).
53. M. K. Marschütz, A. Bernkop-Schnürch. Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) andtheir influence on mucoadhesion. Eur J Pharm Sci 15:387-94 (2002).
54. C. E. Kast, A. Bernkop-Schnürch. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345-52 (2001).
55. J. R. Gum Jr, J. W. Hicks, N. W. Toribara, E. M. Rothe, R. E. Lagace, Y. S. Kim. The human MUC2 intestinal mucin has cycteinerich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem 267:21375-83 (1992).
56. C. M. Lehr. Lectin-mediated drug delivery: the second generation of bioadhesives. J Control Release 65:19-29 (2000).
57. H. L. Lueßen, C. M. Lehr, C. O. Rentel, A. B. J. Noach, A. G. de Boer, J. C. Verhoef, H. E. Junginger. Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Release 29:329-38 (1994).
58. H. L. Lueßen, J. C. Verhoef, G. Borchard, C. M. Lehr, A. G. de Bore, H. E. Junginger. Mucoadhesive polymers in peroral peptide drug delivery: II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res 12:1293-98 (1995).
59. R. Anders, H. P. Merkle. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int J Pharm 49:231-40 (1989).
60. K. Khanvilkar, M. D. Donovan, D. R. Flanagan. Drug transfer through mucus. Adv Drug Deliv Rev 48:173-93 (2001).
61. A. C. Jain, B. J. Aungst, M. C. Adeyeye. Development and in vivo evaluation of buccal tablets prepared using danazolsulfobutylether 7 β-cyclodextrin (SBE 7) complexes. J Pharm Sci 91:1659-68 (2002).
62. M. E. de Vries, H. E. Boddé, J. C. Verhoef, H. E. Junginger. Developments in buccal drug delivery. Crit. Rev Ther Drug Carr Syst 8:271-303 (1991).
63. H. L. Lueßen, J. C. Verhoef, A. G. de Bore, H. E. Junginger, B. J. de Leeuw, G. Borchard, C. M. Lehr. Multifunctional polymers for the peroral delivery of peptide drugs. In: E. Mathiowitz, D. E. Chickering III, C. M. Lehr (eds.), Bioadhesive drug delivery systems. Fundamentals, novel approaches, and development. Marcel Dekker, New York, 1999, pp. 299-339.
64. H. S. Ch'ng, H. Park, P. Kelly, J. R. Robinson. Bioadhesive polymers as platforms for oral controlled drug delivery: II. Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci 74:399-405 (1985).
65. H. Park, J. R. Robinson. Physico-chemical properties of water insoluble polymers important to mucin epithelial adhesion. J Control Release 2:47-57 (1985).
66. E. M. Rudnic, J. D. Schwartz. Oral solid dosage forms. In: A. R. Gennaro (editor). Remington: the science and practice of pharmacy, 20th ed. Lippincott Williams & Wilkins, Baltimore, MD, 2000, pp. 858-59.
67. S. C. Miller, M. D. Donovan. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm 12:147-52 (1982).
68. C. F. Wong, K. H. Yuen, K. K. Peh. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm 178:11-22 (1999).
69. S. Kumar, B. O. Haglund, K. J. Himmelstein. In situ-forming gels for ophthalmic drug delivery. J Ocul Pharmacol 10:47-56 (1994).
70. R. Gurny, J. E. Ryser, C. Tabatabay, M. Martenet, P. Edman, O. Camber. Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy. Graefe Arch Clin Exp Ophthalmol 228:510-12 (1990).
71. G. Meseguer, R. Gurny, P. Buri. Gamma scintigraphic evaluation of precorneal clearance in human volunteers and in rabbits. Eur J Drug Metab Pharmacokinet 18:190-94 (1993).
72. L. Martin, C. G. Wilson, F. Koosha, I. F. Uchegbu. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm 55:35-45 (2003).
73. G. M. Gaeta, F. Gombos, F. Femiano, C. Battista, P. Minghetti, L. Montanari, R. A. Satriano, G. Argenziano. Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release. J Eur Acad Dermatol Venereol 14:473-478 (2000).
74. A. H. Shojaei, B. Berner, X. Li. Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm Res 15:1182-88 (1998).
75. A. H. Shojaei, S. L. Zhuo, X. Li. Transbuccal delivery of acyclovir: II. Feasibility, system design, and in vitro permeation studies. J Pharm Pharm Sci 1:66-73 (1998).
76. S. Rossi, G. Sandri, F. Ferrari, M. C. Bonferoni, C. Caramella. Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharm Dev Technol 8:199-208 (2003).
77. S. S. Strickland, G. V. Veena, P. J. Houghton, S. C. Stanford, A. V. Kurpad. Areca nut, energy metabolism and hunger in Asian men. Ann Hum Biol 30:26-52 (2003).
78. B. Parodi, E. Russo, P. Gatti, S. Cafaggi, G. Bignardi. Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev Ind Pharm 25:289-95 (1999).
79. J. H. Guo. Bioadhesive polymer buccal patches for buprenorphine controlled delivery: formulation, in-vitro adhesion and release properties. Drug Dev Ind Pharm 20:2809-21 (1994).
80. J. H. Guo, K. M. Cooklock. The effects of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches. J Pharm Pharmacol 48:255-57 (1996).
81. G. D{stroke}kinci, Y. Çapan, S. Senel, E. Alaaddinoǧlu, T. Dalkara, A. A. Hi{dotless}ncal. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine. Pharmazie 55:762-65 (2000).
82. N. A. Nafee, N. A. Boraie, F. A. Ismail, L. M. Mortada. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm 53:199-212 (2003).
83. G. D{stroke}kinci, S. Senel, H. Aki{dotless}nci{dotless}bay, S. Kas, S. Ercis, C. G. Wilson, A. A. Hi{dotless}ncal. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm 235:121-27 (2002).
84. A. H. C. Vinholis, L. C. de Figueiredo, E. Marcantonio Jr, R. A. C. Marcantonio, S. L. S. Salvador, G. Goissis. Subgingival utilization of a 1 % chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz Dent J 12:209-13 (2001).
85. D. S. Jones, A. D. Woolfson, A. F. Brown. Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res 14:450-57 (1997).
86. D. S. Jones, A. F. Brown, A. D. Woolfson, A. C. Dennis, L. J. Matchett, S. E. J. Bell. Examination of the physical state of chlorhexidine within viscoelastic, bioadhesive semisolids using raman spectroscopy. J Pharm Sci 89:563-71 (2000).
87. P. Giunchedi, C. Juliano, E. Gavini, M. Cossu, M. Sorrenti. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm 53:233-39 (2002).
88. D. S. Jones, N. J. Medlicott. Casting solvent controlled release of chlorhexidine from ethylcellulose films prepared by solvent evaporation. Int J Pharm 114:257-61 (1995).
89. S. Senel, G. D{stroke}kinci, S. Kas, A. Yousefi{dotless}-Rad, M. F. Sargon, A. A. Hi{dotless}ncal. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm 193:197-203 (2000).
90. D. Tiwari, D. Goldman, R. Sause, P. L. Madan. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci 1:E13 (1999).
91. D. Tiwari, D. Goldman, C. Town, R. Sause, P. L. Madan. In vitro-in vivo evaluation of a controlled release buccal bioadhesive device for oral drug delivery. Pharm Res 16:1775-80 (1999).
92. J. Cassidy, B. Berner, K. Chan, V. John, S. Toon, B. Holt, M. Rowland. Human transbuccal absorption of diclofenac sodium from a prototype hydrogel delivery device. Pharm Res 10:126-29 (1993).
93. B. Singh, N. Ahuja. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm 28:431-42 (2002).
94. A. Ahuja, M. Dogra, S. P. Agarwal. Development of buccal tablets of diltiazem hydrochloride. Indian J Pharm Sci 57:26-30 (1995).
95. G. J. Rhee, D. K. Lee, K. H. Sin, C. B. Park. Formulation and pharmaceutical properties of mucoadhesive films containing dipotassium glycyrrhizate. J Korean Pharm Sci 29:127-36 (1999).
96. K. Tsutsumi, Y. Obata, T. Nagai, T. Loftsson, K. Takayama. Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. Int J Pharm 238:161-70 (2002).
97. P. Bottenberg, R. Cleymaet, K. Röhrkasten, F. Lampert. Microhardness changes in surface enamel after application of bioadhesive fluoride tablets in situ. Clin. Oral Investig 4:153-156 (2000).
98. N. Vivien-Castioni, R. Gurny, P. Baehni, V. Kaltsatos. Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses. Eur J Pharm Biopharm 49:27-33 (2000).
99. D. S. Jones, C. R. Irwin, A. D. Woolfson, J. Djokic, V. Adams. Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. J Pharm Sci 88:592-98 (1999).
100. R. Ilango, S. Kavimani, A. R. Mullaicharam, B. Jayakar. In vitro studies on buccal strips of glibenclamide using chitosan. Indian J Pharm Sci 59:232-35 (1997).
101. M. K. Gutniak, H. Larsson, S. J. Heiber, O. T. Juneskans, J. J. Holst, B. Ahrén. Potential therapeutic levels of glucagon-like peptide I achived in humans by a buccal tablet. Diabetes Care 19:843-48 (1996).
102. M. K. Gutniak, H. Larsson, S. W. Sanders, O. Juneskans, J. J. Holst, B. Ahrén. GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions. Diabetes care 20:1874-79 (1997).
103. M. Oguchi, N. Shikama, S. Sasaki, K. Gomi, Y. Katsuyama, S. Ohta, M. Hori, K. Takei, K. Arakawa, S. Sone. Mucoadhesive watersoluble polymer film for treatment of acute radiation-induced oral mucositis. Int J Radiat Oncol Biol Phys 40:1033-37 (1998).
104. G. C. Ceschel, P. Maffei, S. Lombardi Biogia, C. Ronchi. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv 8:161-71 (2001).
105. W. A. Ritschel, G. B. Ritschel, H. Forusz, M. Kraeling. Buccal absorption of insulin in the dog. Res Commun Chem Pathol Pharmacol 63:53-67 (1989).
106. E. A. Hosny, S. A. Elkheshen, S. I. Saleh. Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll Chim Farm 141:210-17 (2002).
107. M. Ishida, Y. Machida, N. Nambu, T. Nagai. New mucosal dosage form of insulin. Chem Pharm Bull (Tokyo) 29:810-16 (1981).
108. M. E. Kuipers, J. Heegsma, H. I. Bakker, D. K. F. Meijer, P. J. Swart, E. W. Frijlink, A. C. Eissens, H. G. de Vries-Hospers, J. J. M. van den Berg. Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv 9:31-38 (2002).
109. H. Okamoto, H. Taguchi, K. Iida, K. Danjo. Development of polymer film dosage forms of Lidocaine for buccal administration: I. Penetration rate and release rate. J Control Release 77:253-60 (2001).
110. H. Okamoto, T. Nakamori, Y. Arakawa, K. Iida, K. Danjo. Development of polymer film dosage forms of Lidocaine for buccal administration: II. Comparison of preparation methods. J Pharm Sci 91:2424-32 (2002).
111. Y. T. F. Tan, K. K. Peh, O. Al-Hanbali. Effect of carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels. AAPS PharmSciTech 1:E24 (2000).
112. I. M. Brook, G. T. Tucker, E. C. Tuckley, R. N. Boyes. A lignocaine patch for dental analgesia safety and early pharmacology. J Control Release 10:183-88 (1989).
113. N. Parvez, A. Ahuja, R. K. Khar. Development and evaluation of mucoadhesive buccal tablets of lignocaine hydrochloride. Indian J Pharm Sci 64:563-67 (2002).
114. S. Nakane, M. Kakumoto, K. Yukimatsu, Y. W. Chien. Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm Dev Technol 1:251-59 (1996).
115. L. Bénès, B. Claustrat, F. Horrière, M. Geoffriau, J. Konsil, K. A. Parrott, G. DeGrande, R. L. McQuinn, J. W. Ayres. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J Pharm Sci 86:1115-19 (1997).
116. A. Ahuja, R. K. Khar, R. Chaudhry. Evaluation of buccoadhesive metronidazole tablets: microbiological response. Pharmazie 53:264-67 (1998).
117. L. Perioli, V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi, C. Rossi. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 95:521-33 (2004).
118. F. A. Mohammed, H. Khedr. Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow release tablets containing miconazole nitrate. Drug Dev Ind Pharm 29:321-37 (2003).
119. S. Bouckaert, H. Schautteet, R. A. Lefebvre, J. P. Remon, R. van Clooster. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel. Eur J Clin Pharmacol 43:137-40 (1992).
120. S. Bouckaert, R. A. Lefebvre, J. P. Remon. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet. Pharm Res 10:853-56 (1993).
121. S. Bouckaert, R. A. Lefebvre, F. Colardyn, J. P. Remon. Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slowrelease tablet of miconazole. Eur J Clin Pharmacol 44:331-35 (1993).
122. S. Bouckaert, J. P. Remon. In-vitro bioadhesion of a buccal, miconazole slowrelease tablet. J Pharm Pharmacol 45:504-07 (1993).
123. J. Van Roey, M. Haxaire, M. Kamya, I. Lwanga, E. Katabira. Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr 35:144-50 (2004).
124. E. Beyssac, F. Touaref, M. Meyer, L. Jacob, P. Sandouk, J. M. Aiache. Bioavailability of morphine after administration of a new bioadhesive buccal tablet. Biopharm Drug Dispos 19:401-05 (1998).
125. S. Anlar, Y. Çapan, O. Güven, A. Göǧüs, T. Dalkara, A. A. Hi{dotless}ncal. Formulation and in vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets. Pharm Res 11:231-36 (1994).
126. R. Y. Han, J. Y. Fang, K. C. Sung, O. Y. P. Hu. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm 177:201-09 (1999).
127. C. R. Park, D. L. Munday. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 237:215-26 (2002).
128. G. D{stroke}kinci, S. Senel, C. G. Wilson, M. Sumnu. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int J Pharm 277:173-78 (2004).
129. T. Save, M. U. Shah, A. R. Ghamande, P. Venkitachalam. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine. J Pharm Pharmacol 46:192-95 (1994).
130. C. Remuñán-López, A. Portero, J. L. Vila-Jato, M. J. Alonso. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release 55:143-52 (1998).
131. S. Bouckaert, J. P. Remon. In-vitro bioadhesion of a buccal, miconazole slowrelease tablet. J Pharm Pharmacol 45:504-07 (1993).
132. H. G. Choi, J. H. Jung, C. S. Yong, C. D. Rhee, M. K. Lee, J. H. Han, K. M. Park, C. K. Kim. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J Control Release 68:405-12 (2000).
133. H. G. Choi, C. K. Kim. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release 68:397-404 (2000).
134. C. Li, P. P. Bhatt, T. P. Johnston. In vitro release and permeation of oxytocin from a mucoadhesive buccal patch. Pharm Dev Technol 1:357-64 (1996).
135. C. Li, P. P. Bhatt, T. P. Johnston. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm Dev Technol 2:265-74 (1997).
136. V. Agarwal, B. Mishra. Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm 25:701-09 (1999).
137. B. Dortunç, L. Özer, N. Uyanik. Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev Ind Pharm 24:281-88 (1998).
138. M. Jug, M. Bećirević-Laćan. Influence of hydroxypropyl-β-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 21:251-60 (2004).
139. G. C. Ceschel, P. Maffei, A. Sforzini, S. Lombardi Borgia, A. Yasin, C. Ronchi. In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis. Fitoterapia 73(1):S44-52 (2002).
140. N. Çelebi, O. Kislal. Development and evaluation of a buccoadhesive propranolol tablet formulation. Pharmazie 50:470-72 (1995).
141. J. Akbari, A. Nokhodchi, D. Farid, M. Adrangui, M. R. Siahi-Shadbad, M. Saeedi. Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers. IL Farmaco 59:155-61 (2004).
142. N. A. Osipova, G. A. Novikov, M. S. Vetsheva, B. M. Prokhorov, V. A. Beresnev, N. A. Loseva, S. Yu. Zemskaya, T. A. Smolina. Prosidol, a new Russian narcotic analgesic: the first results in oncology. Anesteziol Reanimatol 53-7 (1994).
143. J. S. Park, J. I. Yoon, H. Li, D. C. Moon, K. Han. Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel. Arch Pharm Res 26:659-65 (2003).
144. Z. Cui, R. J. Mumper. Buccal transmucosal delivery of calcitonin in rabbits using thinfilm composites. Pharm Res 19:1901-06 (2002).
145. H. H. Alur, J. D. Beal, S. I. Pather, A. K. Mitra, T. P. Johnston. Evaluation of a novel, natural oligosaccharide gum as a sustainedrelease and mucoadhesive component of calcitonin buccal tablets. J Pharm Sci 88:1313-19 (1999).
146. M. Diarra, G. Pourroy, C. Boymond, D. Muster. Fluoride controlled release tablets for intrabuccal use. Biomaterials 24:1293-1300 (2003).
147. M. I. Mohamed, N. D. Mortada. Development and characterization of a buccoadhesive dosage form of terbutaline sulphate. Mansoura J Pharm Sci 16:69-81 (2000).
148. D. Ameye, J. Voorspoels, P. Foreman, J. Tsai, P. Richardson, S. Geresh, J. P. Remon. Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures. J Control Release 79:173-82 (2002).
149. J. Voorspoels, J. P. Remon, W. Eechaute, W. Sy De. Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs. Pharm Res 13:1228-32 (1996).
150. R. J. M. Ross, A. Jabbar, T. H. Jones, B. Roberts, K. Dunkley, J. Hall, A. Long, H. Levine, D. R. Cullen. Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men. Eur J Endocrinol 150:57-63 (2004).
151. S. Jay, W. Fountain, Z. Cui, R. J. Mumper. Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks. J Pharm Sci 91:2016-25 (2002).
152. M. Minabe, K. Takeuchi, T. Tamura, T. Hori, T. Umemoto. Subgingival administration of tetracycline on a collagen film. J Periodontol 60:552-56 (1989).
153. D. S. Jones, A. D. Woolfson, A. F. Brown, W. A. Coulter, C. McClelland, C. R. Irwin. Design, characterization and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release 67:357-68 (2000).
154. D. S. Jones, A. D. Woolfson, J. Djokic, W. A. Coulter. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 13:1734-38 (1996).
155. S. Geresh, G. Y. Gdalevsky, I. Gilboa, J. Voorspoels, J. P. Remon, J. Kost. Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release. J Control Release 94:391-99 (2004).
156. M. Artusi, P. Santi, P. Colombo, H. E. Junginger. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int J Pharm 250:203-13 (2003).
157. C. Li, R. L. Koch, V. A. Raul, P. P. Bhatt, T. P. Johnston. Absorption of thyrotropinreleasing hormone in rats using a mucoadhesive buccal patch. Drug Dev Ind Pharm 23:239-46 (1997).
158. W. Schurr, B. Knoll, R. Ziegler, R. Anders, H. P. Merkle. Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects. J Endocrinol Invest 8:41-4 (1985).
159. S. Senel, M. J. Kremer, S. Kas, P. W. Wertz, A. A. Hi{dotless}ncal, C. A. Squier. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 21:2067-71 (2000).
160. S. C. Shin, J. P. Bum, J. S. Choi. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int J Pharm 209:37-43 (2000).
161. S. C. Shin, J. Y. Kim. Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur J Pharm Biopharm 50:217-20 (2000).
162. M. Diarra, G. Pourroy, D. Muster, M. Zingraff, C. Boymond. Elaboration and evaluation of an intraoral controlled release delivering system. Biomaterials 19:1523-27 (1998).
163. D. Accili, G. Menghi, G. Bonacucina, P. Martino, G. Palmieri. Mucoadhesion dependence of pharmaceutical polymers on mucosa characteristics. Eur J Pharm Sci 22:225-34 (2004).
164. A. G. Mikos, N. A. Peppas. Systems for controlled release of drugs. V: Bioadhesive systems. STP Pharma Sci 19:705-15 (1986).
165. J. D. Smart, I. W. Kellaway, H. E. Worthington. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 36:295-99 (1984).
166. C. Wong, K. Yuen, K. Peh. An in-vitro method for buccal adhesion studies: importance of instrument variables. Int J Pharm 180:47-57 (1999).
167. S. H. Leung, J. R. Robinson. The contribution of anionic polymer structural features to mucoadhesion. J Control Release 5:223-31 (1988).
168. S. A. Mortazavi, J. D. Smart. An investigation of some factors influencing the in vitro assessment of mucoadhesion. Int J Pharm 116:223-30 (1995).
169. R. Riley, J. Smart, J. Tsibouklis, P. Dettmar, F. Hampson, J. A. Davis, G. Kelly, W. Wilber. An investigation of mucus/polymer rheological synergism using synthesized and characterized poly(acrylic acid)s. Int J Pharm 217:87-100 (2001).
170. E. E. Hassan, J. M. Gallo. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 7:491-95 (1990).
171. K. Park, J. R. Robinson. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharm 19:107-127 (1984).
172. H. Takeuchi, J. Thongborisute, Y. Matsui, H. Sugihara, H. Yamamoto, Y. Kawashima. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 57:1583-94 (2005).